Glycoscoredx

Developer of a diagnostic test for the detection of prostate cancer

placeNewcastle Upon Tyne, England, United Kingdom calendar_todayFounded 2020 groups2 employees language glycoscoredx.co.uk

Registered entities

Innovation

1 patent family (1 granted) — focus: Physics & computing; filing pace slowing. Cited 9 times.

YearFilings
20221
20231

Investor mix

5 investors on record; lead investors include Northstar Ventures, Northern Accelerator, Milltrust International Group, Oxbridge Capital.

Investor typeCountShare
Venture capital360%
Accelerator & incubator120%
Other / undisclosed120%
Coming soon